CTT Pharmaceutical Holdings, Inc.
CTTH
$0.08
$0.00-0.63%
OTC PK
| 12/31/2024 | 06/30/2015 | 03/31/2015 | 12/31/2014 | 09/30/2014 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | -- | 1.12M | 877.90K | 666.80K | 53.30K |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -- | 1.12M | 877.90K | 666.80K | 53.30K |
| Operating Income | -- | -1.12M | -877.90K | -666.80K | -53.30K |
| Income Before Tax | -- | -1.37M | -1.01M | -674.30K | -53.30K |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -- | -1.37 | -1.01 | -0.67 | -0.05 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -- | -1.37M | -1.01M | -674.30K | -53.30K |
| EBIT | -- | -1.12M | -877.90K | -666.80K | -53.30K |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | -- | -0.07 | -0.05 | -0.03 | 0.00 |
| Normalized Basic EPS | -- | -0.04 | -0.03 | -0.02 | 0.00 |
| EPS Diluted | -- | -0.07 | -0.05 | -0.03 | 0.00 |
| Normalized Diluted EPS | -- | -0.04 | -0.03 | -0.02 | 0.00 |
| Average Basic Shares Outstanding | -- | 76.34M | 69.94M | 65.35M | 60.52M |
| Average Diluted Shares Outstanding | -- | 76.34M | 69.94M | 65.35M | 60.52M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |